Monday, January 20, 2025

Music therapy joins stroke rehabilitation service at Doncaster hospital

 WOW! How out-of-date can you be and still be considered a hospital? Serious question. I'd suggest firing the board of directors for incompetence!

Music therapy joins stroke rehabilitation service at Doncaster hospital

"Music has so many healing elements, and I’m grateful for the chance to advocate for its benefits. When you attend Music Therapy sessions, you can expect a non-judgmental, safe space to explore your thoughts and feelings.

“The biggest myth around music therapy is that you need to sing or play an instrument—don’t worry, you don’t need any special talent. My role is to help you regain speech, strengthen muscles, and walk with more ease.

“Functional goals are at the heart of each session, whether we’re singing to improve speech, playing instruments to build motor skills, or simply using music as a tool to enhance your recovery.

“I want to help you achieve your goals and use music to drive those changes. Yes, it’s enjoyable because we integrate rehab with music, but it’s also incredibly effective.”

The Trust has also secured charitable funding through the Fred and Ann Green Legacy for several pioneering machines that will aid in the upper and lower limb mobility of stroke patients, supporting exercises that accelerate recovery.

The machines will be based within a new gymnasium to be built as part of a £1.4 million investment in the stroke rehabilitation service at Montagu Hospital, and set to open in Summer 2025.

DBTH, said: “The new robotic therapy suite will be a first for the NHS, utilising technology previously restricted to patients receiving private healthcare.

“Our aspiration is to collaborate with colleagues from other Stroke services in the South Yorkshire area, allowing this facility to help Stroke survivors from a wider catchment to better achieve their recovery goals.”

This development follows DBTH being named as one of only four NHS sites in England chosen to trial a new genetic testing service for stroke patients.

This pilot, run by NICE and NHS England, will explore whether Clopidogrel, a common medication used to reduce the risk of further strokes, is the best treatment for patients based on their genetic makeup.

Around 30 per cent of people in the UK, and even more in some ethnic groups, have a variation in this gene that makes the medication less effective.

By identifying these individuals, doctors can prescribe alternative treatments to help prevent future strokes.

For inquiries on supporting DBTH and contributing to future healthcare innovations, please contact the Fundraising and Communications Team at 01302 644244 or dbth.charity@nhs.net

No comments:

Post a Comment